Results 131 to 140 of about 8,385 (178)

Public Health Impact of Introducing a Pentavalent Vaccine Against Invasive Meningococcal Disease in the United States. [PDF]

Pharmacoeconomics
Shah HA, Jutlla G, Herrera-Restrepo O, Graham J, Hicks KA, Carrico J, Grace M, Clements DE, Burman C, Sohn WY, Kuylen E, Begum S, Kocaata Z.   +12 more
europepmc   +1 more source

Public health management of invasive meningococcal disease outbreaks: worldwide 1973-2018, a systematic review. [PDF]

BMC Public Health
Morello BR, Milazzo A, Marshall HS, Giles LC.   +3 more
europepmc   +1 more source

Evaluating the Efficacy of a Serious Game to Deliver Health Education About Invasive Meningococcal Disease: Clustered Randomized Controlled Equivalence Trial. [PDF]

JMIR Serious Games
Bloomfield L, Boston J, Masek M, Andrew L, Barwood D, Devine A.   +5 more
europepmc   +1 more source

Invasive meningococcal disease in older adults: current perspectives and call for action. [PDF]

Eur Geriatr Med
Weil-Olivier C, Taha MK, Leng S, Dinleyici EC, Bonanni P, Moya E, Leischker A, Yezli S.   +7 more
europepmc   +1 more source

Follow-up care experience of patients with invasive meningococcal disease and their family caregivers: a qualitative study. [PDF]

BMC Infect Dis
Baloche A, Bedouch P, Carrouel F, Argaud L, Kolev K, Mortamet G, Schwebel C, Mick G, Dussart C.   +8 more
europepmc   +1 more source

Retrospective analysis of health and economic burden among commercially-insured individuals diagnosed with invasive meningococcal disease in the United States. [PDF]

Hum Vaccin Immunother
Herrera-Restrepo O, Kwiatkowska M, Huse S, Kocaata Z, Ganz ML.   +4 more
europepmc   +1 more source